ALNOV.PA - Novacyt S.A.

Paris - Paris Delayed Price. Currency in EUR
0.2550
+0.0010 (+0.39%)
At close: 5:16PM CEST
Stock chart is not supported by your current browser
Previous Close0.2540
Open0.2540
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2490 - 0.2545
52 Week Range0.2250 - 0.7500
Volume42,655
Avg. Volume230,993
Market Cap9.577M
Beta (3Y Monthly)-0.01
PE Ratio (TTM)N/A
EPS (TTM)-0.2250
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.25
  • Did Changing Sentiment Drive Novacyt’s (EPA:ALNOV) Share Price Down A Disastrous 96%?
    Simply Wall St.last month

    Did Changing Sentiment Drive Novacyt’s (EPA:ALNOV) Share Price Down A Disastrous 96%?

    Long term investing works well, but it doesn't always work for each individual stock. We don't wish catastrophic capital loss on anyone. Spare a thought for those who held NovacytRead More...

  • Simply Wall St.6 months ago

    Novacyt SA (EPA:ALNOV): Are Analysts Optimistic?

    Novacyt SA’s (EPA:ALNOV): Novacyt S.A. develops and sells diagnostic products for cancer and infectious diseases. The company’s loss has recently broadened since it announced a -€5m loss in the full Read More...

  • Business Wire10 months ago

    Novacyt: Update on Unsecured Debt Facility

    AIM: NCYT), an international specialist in clinical diagnostics, announces the conversion of the €4.0m unsecured, anti-dilutive debt facility (the “Advance”) from a French institutional investor, into an unsecured Convertible Bond (the “Convertible Bond”) further to the announcement on 30 May 2018. The Convertible Bond will be issued on 30 June 2018 following the successful outcome of the Extraordinary General Meeting (EGM) on 11 June 2018, which granted the Company sufficient authorities to issue equity. The Convertible Bond will be issued in a single tranche with a maturity of three years and bears an annual interest rate of 7.4%.

  • Business Wire10 months ago

    Novacyt Launches New Product in Infectious Mononucleosis

    Regulatory News:

  • Novacyt Société Anonyme (EPA:ALNOV): Is Breakeven Near?
    Simply Wall St.11 months ago

    Novacyt Société Anonyme (EPA:ALNOV): Is Breakeven Near?

    Novacyt Société Anonyme’s (ENXTPA:ALNOV): Novacyt Société Anonyme develops and sells diagnostic products for cancer and infectious diseases. The €25.56M market-cap company announced a latest loss of -€5.44M on 31 DecemberRead More...